13.64 USD
↘ 1.02 (6.96%)LIVE (AS OF 11:54 AM EST)
Lyell Immunopharma, Inc. Common Stock (LYEL) is currently trading at $13.64. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place LYEL at a fair price relative to peers.
Technical & fundamental data as of Nov 16, 2026.